Related Experiment Video
Updated: Jun 23, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Asthma patients' self-reported behaviours toward inhaled corticosteroids
Laurent Laforest1, Abdelkader El Hasnaoui, Céline Pribil
1CHU Lyon, Unité de Pharmacoépidémiologie, Service de Neurologie, Hôpital Pierre Wertheimer, 59 Boulevard Pinel, Bron, France.
Asthma patients often stop using inhaled corticosteroids (ICS) due to misconceptions or forgetfulness. Interventions should address these patient beliefs and behaviors to improve adherence to controller therapy.
Area of Science:
- Pulmonary Medicine
- Behavioral Science
Background:
- Patient adherence to inhaled corticosteroids (ICS) in asthma management is frequently suboptimal, characterized by irregular use or treatment interruptions.
- Understanding the factors contributing to the discontinuation of controller therapy is crucial for developing effective interventions.
Purpose of the Study:
- To investigate the characteristics and behaviors of asthma patients who interrupt their prescribed inhaled corticosteroids (ICS), whether intentionally or accidentally.
- To identify correlates of ICS interruptions to inform targeted patient support strategies.
Main Methods:
- A study included asthma patients prescribed ICS by general practitioners, utilizing self-report questionnaires and prescription data.
- Patient behaviors such as intentional/accidental ICS interruptions, reduced usage, and dose changes were assessed.
- Multiple Component Analysis (MCA) was employed to study interrelations between declared behaviors and identify correlates of ICS interruptions.
Main Results:
- 31.6% of patients intentionally interrupted ICS when feeling better, 25.4% forgot doses, and 18.3% deliberately altered doses.
- A significant correlation was found between intentional, accidental interruptions, and less frequent ICS use.
- Beliefs that constant respiratory therapy is unhealthy increased the risk of intentional interruption (OR=3.36), while ICS combination therapy decreased this risk (OR=0.24). Patients over 65 showed less frequent interruptions (OR=0.35).
Conclusions:
- Discontinuation of controller therapy in asthma is linked to other maladaptive behaviors and misconceptions regarding inhaled controllers.
- Future interventions should focus on modifying patients' perceptions and behaviors concerning controller therapy to enhance adherence.
Related Concept Videos
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma III: Clinical Manifestations
Asthma-I: Introduction
Asthma-IV: Nursing Management
First, in...
Asthma-III: Symptoms and Complications
Classification of Asthma